Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Chamberlain

Showing results (11-20 of 112) with videos related to

Pageof 12
Sort By:
Drugs|January 1, 1987
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Efficacy dataD A Chamberlain
Drugs|January 1, 1987
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Tolerance dataD A Chamberlain
Cardiology|January 1, 1987
Overview of completed sudden death trials: European experienceD A Chamberlain
The American Journal of Cardiology|July 5, 1989
Unanswered questions in thrombolysisD A Chamberlain
Proceedings of the Royal Society of Medicine|October 5, 2010
Coronary care: home or hospitalD A Chamberlain
Resuscitation|October 1, 1991
Lignocaine and bretylium as adjuncts to electrical defibrillationD A Chamberlain
Postgraduate Medical Journal|January 1, 1983
The advantages of a coronary care ambulance systemD A Chamberlain
Advances in Cardiology|January 1, 1978
Beta-adrenergic blocking agents in prevention of sudden deathD A Chamberlain
Postgraduate Medical Journal|November 1, 1974
The relation of clinical effect to plasma digoxin concentrationD A Chamberlain
American Heart Journal|August 1, 1997
Treatment after myocardial infarction: changes in the last decade--a look backD A Chamberlain
Pageof 12

Showing results (11-20 of 112) with videos related to

Sort By:
Pageof 12
Drugs|January 1, 1987
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Efficacy dataD A Chamberlain
Drugs|January 1, 1987
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex in a district hospital. Tolerance dataD A Chamberlain
Cardiology|January 1, 1987
Overview of completed sudden death trials: European experienceD A Chamberlain
The American Journal of Cardiology|July 5, 1989
Unanswered questions in thrombolysisD A Chamberlain
Proceedings of the Royal Society of Medicine|October 5, 2010
Coronary care: home or hospitalD A Chamberlain
Resuscitation|October 1, 1991
Lignocaine and bretylium as adjuncts to electrical defibrillationD A Chamberlain
Postgraduate Medical Journal|January 1, 1983
The advantages of a coronary care ambulance systemD A Chamberlain
Advances in Cardiology|January 1, 1978
Beta-adrenergic blocking agents in prevention of sudden deathD A Chamberlain
Postgraduate Medical Journal|November 1, 1974
The relation of clinical effect to plasma digoxin concentrationD A Chamberlain
American Heart Journal|August 1, 1997
Treatment after myocardial infarction: changes in the last decade--a look backD A Chamberlain
Pageof 12